Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), CytomX Therapeutics Inc (NASDAQ:CTMX), Gyre Therapeutics Inc (NASDAQ:GYRE), Valneva SE (NASDAQ:VALN) and 4D Molecular Therapeutics Inc (NASDAQ:FDMT).
Emergent BioSolutions has a consensus price target of $14.75.
The stock price for Emergent BioSolutions (NYSE: EBS) is $12.35 last updated December 18, 2025 at 11:23 AM EST.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions does not have any upcoming earnings scheduled.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.